GS1 revs track/trace engine; Lean vs. innovation;

> This week marks the start of a GS1 "test engine" effort to help pharma and healthcare companies prep for upcoming drug track-and-trace requirements. Article

> True or false? Lean techniques, while valuable in manufacturing, supply chain, and other work involving formal processes, are detrimental to innovation. Article

> Notification workflow software is making its way to the regulated realm of drug making. Article

> The London-based International Society of Pharmacovigilance has named its next president: Alex Dodoo, president of the Pharmaceutical Society of Ghana. Article

> The $799 Pharmaceutical Preparation Manufacturing Industry report notes 11 percent constant annual growth over the past three years and a large dependency on personal consumption. Announcement

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)